-+ 0.00%
-+ 0.00%
-+ 0.00%

Allogene Therapeutics Faces Potential Risk as Cellectis Hit with Patent Infringement Lawsuit Over TALEN Gene-Editing Technology

Reuters·10/14/2025 10:01:17

Please log in to view news